Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma
Clinical trial NCT07347210 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07347210
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2029-01-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.